Patient complaints drop after amalgam fillings replaced
Removing amalgam fillings from patients with a history of health complaints dramatically reduced the number of complaints, according to a small study in Acta Odontologica
Removing amalgam fillings from patients with a history of health complaints dramatically reduced the number of complaints, according to a small study in Acta Odontologica
Horizon Technology Finance, a specialty finance company, has closed a $3 million revolving credit facility with OraMetrix, the provider of the SureSmile system for orthodontics.
Dirk Kirsten, chief financial officer (CFO) of dental implant provider Nobel Biocare, will resign, effective January 31, 2013. Kirsten will pursue other opportunities outside of
3D Systems, a provider of 3D content-to-print dental solutions, has become a corporate underwriter of the National Children’s Oral Health Foundation (NCOHF). Through the support
The city of Calgary, Alberta, has earmarked $750,000 saved from discontinuing its water fluoridation program for oral health programs targeting children from poor families, according
NEW YORK (Reuters Health) – The breathing problems caused by sleep apnea appear to worsen during the colder months of the year, according to a
Align Technology has responded to a press release issued on June 28, 2012, by ClearCorrect relating to the stay issued nearly two months ago of
The Indiana Attorney General’s (AG) Office has filed an administrative complaint with the Indiana State Board of Dentistry against Allcare Dental & Dentures President Robert
Australians are paying extra for so-called whitening toothpastes that contain no bleaching agents, according to Choice, a consumer watchdog group. The organization reviewed 17 toothpaste
Dear DrBicuspid Member, In part two of its comprehensive investigative report on corporate dental chains and their increasing — and sometimes questionable — role in
A systematic review published last year in the Journal of Dental Research (JDR) found little evidence to support the use of oxalates for treating dentin
Delta Dental of Michigan has invested $3 million in Interleukin Genetics to advance the company’s periodontal disease susceptibility risk test. The investment includes the purchase